Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
Phase 2
Active, not recruiting
- Conditions
- Solid Tumors
- Interventions
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Yancheng First People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05522582
- Locations
- 🇨🇳
Yancheng First People's Hospital, Yancheng, Jiangsu, China
News
No news found